Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-standard T1D care. Our Australian AID trial shows a wide spectrum of adults with T1D can achieve recommended targets. Other studies, including lived experience data, are supportive. Insulin pumps are not subsidised for most Australian adults with T1D. We advocate change.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/imj.16567 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Automated Insulin Delivery Systems and Glucose Management in Children and Adolescents With Type 1 Diabetes: A Systematic Review and Meta-Analysis.
JAMA Pediatr
September 2025
Diabetes Research Envisioned and Accomplished in Manitoba (DREAM) Research Theme, Children's Hospital Research Institute of Manitoba, Winnipeg, Canada.
Importance: Youth living with type 1 diabetes (T1D) are increasingly choosing automated insulin delivery (AID) systems to manage their blood glucose. Few systematic reviews meta-analyzing results from randomized clinical trials (RCTs) are available to guide decision-making.
Objective: To study the association of prolonged AID system use in an outpatient setting with measures of glucose management and quality of life in youth with T1D.
Real-time converter of intermittent-scanned glucose sensors to continuous glucose monitors with potential future applications for insulin delivery.
HardwareX
September 2025
Universidad Nacional de Colombia, Facultad de Minas, Grupo GITA, Cra. 80#65-223, Colombia.
This paper presents the development of a transmitter that transforms intermittent glucose sensors (isCGM) into a continuous and real-time glucose monitoring system (c-rtCGM), a key component in automated insulin delivery systems. The transmitter enhances the capabilities of conventional intermittent sensors by leveraging Near Field Communication (NFC) technology to capture raw glucose value and automatically transmit it via Bluetooth Low Energy (BLE-Bluetooth 4.2 Dual-Mode) to a smart device every five minutes.
View Article and Find Full Text PDFReal-World Clinical Impact of Using Personal Glucose Targets in a Hybrid Closed-Loop System Differs According to Age.
Diabetes Technol Ther
September 2025
Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, United Kingdom.
CamAPS FX is a customizable hybrid closed-loop app with a default target glucose of 105 mg/dL. The personal glucose target is user-adjustable in 1 mg/dL increments between 80 and 198 mg/dL in 30-min segments over 24 h. We assessed the impact of different personal glucose targets on glycemic control during real-world use of CamAPS FX in different age-groups.
View Article and Find Full Text PDFUnveiling the Metabolic Burden: A Clinicopathological Study of Chronic Plaque Psoriasis and Its Association With Metabolic Syndrome.
Cureus
August 2025
Department of Pathology, Mahatma Gandhi Memorial Medical College, Indore, IND.
Introduction Psoriasis is a chronic, immune-mediated inflammatory skin disease with systemic manifestations. Among its significant comorbidities, metabolic syndrome (MS) - a constellation of obesity, hypertension, dyslipidemia, and insulin resistance - has gained recognition due to its association with increased cardiovascular risk and reduced life expectancy. Chronic systemic inflammation, shared immunological pathways, and elevated pro-inflammatory cytokines are thought to underlie this association.
View Article and Find Full Text PDFValidation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control.
PLoS One
September 2025
Grupo GITA, Facultad de Minas, Universidad Nacional de Colombia, Medellín, Colombia.
The development of an impulsive automated insulin delivery system (i-AiDS) for type 1 diabetes mellitus aims to provide real-time blood glucose regulation with minimal human intervention. This study presents the validation of an offset-free impulsive zone model predictive control strategy designed to cope with external disturbances such as meal intake and plant-model mismatch in a diabetic rat model. Fourteen male Wistar rats induced diabetes with streptozotocin were monitored using an continuous glucose monitoring and regulated by delivering insulin with a customized low-cost pump.
View Article and Find Full Text PDF